GlassScriptPhysician profile
Scott M Fine
NPI 1023138260
$911.56
in general payments reported to CMS, 2019-2025
7 companies · $206 in 2025
The $206 reported for 2025 was more than what 76% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $13.59 · 2023: $252 · 2024: $439 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $420 · Food and Beverage: $339 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $419.91 |
| Food and Beverage | $339.44 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $138.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $419.91 | 2024-2025 | Opalescence |
| Orapharma, A Division of Bausch Health US, LLC | $161.37 | 2022-2025 | Arestin, Ossix Plus |
| Straumann USA LLC | $138.62 | 2023 | |
| Dentsply Sirona INC | $138.12 | 2024-2025 | Suresmile, Sirolaser Advance |
| Solventum Corporation | $20.45 | 2025 | 3m Scotchbond, Clarity Aligners |
| Carestream Dental, LLC | $19.70 | 2023 | |
| 3m Company | $13.39 | 2023 | 3m Relyx, 3m Espe Filtek Supreme Ultra Universal Restorative, Scotchbond Universal Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Fine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.